Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study

Published:2022-08-17 Issue:13 Volume:63 Page:3063-3071
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Stamatoullas Aspasia¹^ORCID,Ghesquières Hervé²^ORCID,Feugier Pierre³,André Marc⁴,Le Bras Fabien⁵,Gac Anne-Claire⁶,Borel Cécile⁷,Gastinne Thomas⁸,Quittet Philippe⁹,Morschhauser Franck¹⁰,Ribrag Vincent¹¹,Guidez Stephanie¹²,Nicolas-Virelizier Emmanuelle¹³,Berriolo-Riedinger Alina¹⁴,Vander Borght Thierry¹⁵,Edeline Véronique¹⁶,Brice Pauline¹⁷

Affiliation:

1. Département d’Hématologie, Centre Henri Becquerel, Rouen, France

2. Département d’Hématologie, Centre Hospitalier Lyon Sud, Lyon France

3. Département d’Hématologie, CHU Nancy, Nancy, France

4. Département d’Hématologie, CHU UCL, Namur, Belgique

5. Unité Hémopathies Lymphoïdes, Hôpital Henri Mondor, Créteil, France

6. Département d’Hématologie, CHU, Caen, France

7. Département d’Hématologie, IUCT Oncopole, Toulouse, France

8. Département d’Hématologie, CHU Nantes, Nantes, France

9. Département d’Hématologie, CHU Montpellier, Montpellier, France

10. Département d’Hématologie, CHRU Lille, Lille, France

11. Département of Hématologie, Institut Gustave Roussy, Paris, France

12. Service d'Oncologie Hématologique et Thérapie Cellulaire, CHU Poitiers, Poitiers, France

13. Service d’Hématologie, Centre Léon Bérard, Lyon, France

14. Service de Médecine Nucléaire, Centre GF Leclerc, Dijon, France

15. Service de médecine Nucléaire, CHU UCL Namur, Namur, Belgique

16. Service de Médecine Nucléaire, Institut Curie, Hôpital R Huguenin, Saint-Cloud, France

17. Département d’Hématologie, Hôpital Saint Louis, APHP Paris, Paris, France

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2022.2107204

Reference38 articles.

1. Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial

2. ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned

3. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

4. Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG)

5. Risk-Adapted Salvage Treatment With Single or Tandem Autologous Stem-Cell Transplantation for First Relapse/Refractory Hodgkin's Lymphoma: Results of the Prospective Multicenter H96 Trial by the GELA/SFGM Study Group

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What is the best salvage therapy for Hodgkin lymphoma?;Current Opinion in Oncology;2024-06-20

2. The role of autologous stem-cell transplantation in classical Hodgkin lymphoma in the modern era;Seminars in Hematology;2024-06

3. Beyond Chemotherapy: Present and Future Perspectives in the Treatment of Lymphoproliferative Disorders;Biomedicines;2024-04-29

4. Ifosfamide - History, efficacy, toxicity and encephalopathy;Pharmacology & Therapeutics;2023-03

5. Filling the Gap: The Immune Therapeutic Armamentarium for Relapsed/Refractory Hodgkin Lymphoma;Journal of Clinical Medicine;2022-11-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3